We are live on
!
Find out more
TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Est. Return
58.09%
This Fund
S&P 500
This Quarter
Est. Return
+12.92%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$488M
AUM Growth
+$7.56M
(+1.6%)
Cap. Flow
-$33.2M
Cap. Flow
% of AUM
-6.81%
Top 10 Holdings %
Top 10 Hldgs %
49.96%
Holding
83
New
39
Increased
11
Reduced
21
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$24.6M |
| 2 |
CVS Health
CVS
|
+$16.4M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$11.9M |
| 4 |
Bioventus
BVS
|
+$9.61M |
| 5 |
Henry Schein
HSIC
|
+$7.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$16.1M |
| 2 |
Perrigo
PRGO
|
+$15M |
| 3 |
United Therapeutics
UTHR
|
+$13.8M |
| 4 |
Pacira BioSciences
PCRX
|
+$13.2M |
| 5 |
AtriCure
ATRC
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.25% |
| 2 | Consumer Staples | 4.28% |
| 3 | Technology | 4.26% |
| 4 | Consumer Discretionary | 0.47% |
| 5 | Industrials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pacira BioSciences
PCRX
$1.04B
| $38.5M | 7.91% |
550,000
-185,000
| -25% | -$13.2M |
|
2
Medtronic
MDT
$109B
| $35.4M | 7.27% |
300,000
-75,000
| -20% | -$8.79M |
|
3
Rigel Pharmaceuticals
RIGL
$681M
| $28.6M | 5.86% |
835,000
+90,000
| +12% | +$3.56M |
|
|
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
| $24.6M | 5.05% |
+770,000
| New | +$24.6M |
|
5
Turning Point Brands
TPB
$1.45B
| $20.9M | 4.28% |
400,000
+30,000
| +8% | +$1.5M |
|
|
HOLX
6
DELISTED
Hologic
HOLX
| $20.5M | 4.2% |
275,000
| – | – |
|
7
Lantheus
LNTH
$6.49B
| $19.8M | 4.05% |
925,000
-25,000
| -3% | -$454K |
|
8
Quest Diagnostics
DGX
$25.7B
| $19.3M | 3.95% |
150,000
-15,000
| -9% | -$1.85M |
|
9
Labcorp
LH
$25B
| $19.1M | 3.92% |
87,300
-29,100
| -25% | -$5.84M |
|
|
10
CVS Health
CVS
$133B
| $16.9M | 3.47% |
+225,000
| New | +$16.4M |
|
|
11
United Therapeutics
UTHR
$25.8B
| $16.7M | 3.43% |
100,000
-83,000
| -45% | -$13.8M |
|
|
LMNX
12
DELISTED
Luminex Corp
LMNX
| $15.3M | 3.13% |
478,327
+228,327
| +91% | +$6.77M |
|
13
RadNet
RDNT
$5.02B
| $14.9M | 3.06% |
685,000
+35,000
| +5% | +$708K |
|
14
ICU Medical
ICUI
$4.21B
| $14.4M | 2.95% |
70,000
-3,000
| -4% | -$634K |
|
|
MDRX
15
DELISTED
Veradigm Inc. Common Stock
MDRX
| $13.1M | 2.69% |
875,000
-625,000
| -42% | -$10M |
|
|
16
AtriCure
ATRC
$1.92B
| $13.1M | 2.69% |
200,000
-166,400
| -45% | -$10.2M |
|
17
Integer Holdings
ITGR
$4.12B
| $12M | 2.45% |
129,800
+55,800
| +75% | +$4.72M |
|
|
VRAY
18
DELISTED
ViewRay, Inc.
VRAY
| $10.7M | 2.19% |
+2,450,000
| New | +$11.9M |
|
|
19
Bioventus
BVS
$892M
| $10.3M | 2.12% |
+675,000
| New | +$9.61M |
|
|
STRM
20
DELISTED
Streamline Health Solutions
STRM
| $10.1M | 2.07% |
328,725
+41,666
| +15% | +$1.19M |
|
21
Plexus
PLXS
$6.72B
| $10.1M | 2.07% |
110,000
+10,000
| +10% | +$848K |
|
|
NUAN
22
DELISTED
Nuance Communications, Inc.
NUAN
| $9.82M | 2.01% |
225,000
-350,000
| -61% | -$16.1M |
|
23
SI-BONE Inc
SIBN
$788M
| $8.75M | 1.79% |
275,000
-110,000
| -29% | -$3.38M |
|
|
24
Henry Schein
HSIC
$9.77B
| $7.62M | 1.56% |
+110,000
| New | +$7.44M |
|
25
AngioDynamics
ANGO
$611M
| $7.61M | 1.56% |
325,000
-35,000
| -10% | -$707K |
|
Similar funds
SCM
LBC
ICM
LCMP
GIP
STC
GC
DU
Tamarack Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Tamarack Advisers held 83 positions worth $488M, up 1.6% from $480M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Tamarack Advisers withdrew a net $33.2M in Q1 2021, closing 11 positions and reducing 21 holdings. Its most notable exit was Senior Connect Acquisition Corp. I Unit, an estimated $9.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Tamarack Advisers opened a new position in Patterson Companies, Inc. worth $24.6M.
- Tamarack Advisers's largest Q1 2021 buy was Patterson Companies, Inc.: 770,000 shares worth $24.6M.
- Tamarack Advisers added most to Luminex Corp in Q1 2021, an estimated $6.77M increase.
- Tamarack Advisers's biggest Q1 2021 reduction was Nuance Communications, Inc., cutting an estimated $16.1M.
- Tamarack Advisers fully exited Senior Connect Acquisition Corp. I Unit in Q1 2021, selling an estimated $9.84M.
- Tamarack Advisers's ten largest holdings make up 50% of its $488M portfolio in Q1 2021.
- Tamarack Advisers opened 39 new positions and closed 11 in Q1 2021.
- Tamarack Advisers's portfolio value rose 1.6% quarter-over-quarter to $488M.
Based on Tamarack Advisers's 13F filing for Q1 2021, filed 12 May 2021.